De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?

Guillaume Cayla; Benoit Lattuca

doi:10.4244/EIJ-E-23-00046

Retour

De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?

Article de revue

Avec comité de lecture

De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?

Guillaume Cayla et Benoit Lattuca

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol.19(10), pp.e789-e791

04/12/2023

DOI: https://doi.org/10.4244/EIJ-E-23-00046

PMID: 38050993

Résumé

Acute Coronary Syndrome

Aspirin

Clopidogrel - therapeutic use

Hemorrhage

Humans

Percutaneous Coronary Intervention

Platelet Aggregation Inhibitors - therapeutic use

Prasugrel Hydrochloride - therapeutic use

Purinergic P2Y Receptor Antagonists - therapeutic use

Treatment Outcome

Indicateurs

1 Consultations de la notice

Détails

Titre: De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?
Créateurs - sans rôle: Guillaume Cayla - Department of Cardiology, Nimes University Hospital, Montpellier University, ACTION study group, Nimes, France
Benoit Lattuca - Department of Cardiology, Nimes University Hospital, Montpellier University, ACTION study group, Nimes, France
Détails de publication: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol.19(10), pp.e789-e791
Identifiants: 99139907209311
Unité académique: Initial MAnagement & prevent of acute orGan failures IN critically ill patiEnts - IMAGINE
Langue: English
Type de ressource: Journal article